Abattis Bioceuticals Corp. is an agricultural technology and bio-technology company, which aggregates, integrates, and invests in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. It operates through the following segments: Sciences, Products, and Technologies. The Sciences segment engages in research and development and analytical services, primarily through its proposed Northern Vine laboratory plans. The Products segment engages in sale and marketing of proprietary, formulated natural health products and ingredients. The Technologies segment provides systems and technologies that will generate royalties and license fees in support of the botanical drug and natural health product markets. Abattis Bioceuticals was founded on June 30, 1997 and is headquartered in Vancouver, Canada.
Company profile
Ticker
ATTBF
Exchange
Website
CEO
Robert Abenante
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
ABATTIS BIOLOGIX Corp
SEC CIK
Corporate docs
Latest filings (excl ownership)
RW
Registration withdrawal request
9 Dec 16
F-1
Registration statement (foreign)
28 Apr 15
D
$62.55K in equity, sold $62.55K, 1 investor
14 Apr 14
D
$2.49M in equity / options / securities to be acquired, sold $83.71K, 6 investors
3 Apr 14
D
$20.01K in equity, sold $20.01K, 1 investor
21 Mar 12
D/A
$29.73K in equity, sold $29.73K, 3 investors
6 Apr 11
D
$297.27K in equity, sold $297.27K, 3 investors
17 Mar 11
Latest ownership filings
No filings